Pharma consolidation in US hurts mid-sized Indian drug makersSeveral mid-sized Indian drug makers heavily dependent on the United States are beginning to suffer because consolidation in the US pharmac...
US, EU slowdown may keep pharma export growth at 10%: OfficialThe growth of Indian pharma exports during 2012-13 halved to 10.55% over previous year to $ 14.6 bn. During 2011-12 the exports stood at $ ...
Apex pharma trade body to open warehouses abroadTo encourage export business of small and medium pharma companies, Pharmexcil plans to set up warehouse facilities in Latin America, Africa...
India woos Iran with its affordable generic drugsIndia is hard selling its cost effective generic drugs to Iran and competing against the expensive medicines from Europe.
- Pharma exports grew over 23 per cent in 2011-12: Pharmexcil
Indian pharma exports grew by 23.34 per cent in the last fiscal, Pharmaceuticals Export Promotion Council of India (Pharmexcil) said.
Generic business may hit drug exports of Indian firms like Cipla and NatcoIndia exported medicines worth $13.2 billion last fiscal and the government plans to double it to $25 billion by March 2014.
- Pharma body seeks export sops
Pharmexcil, the government’s pharma export monitoring arm, has sought enhanced sops under export promotion schemes and a cut in the interes...